Abstract:Hybridoma technology is widely used for monoclonal antibody (mAb) discovery, whereas the generation and identification of single hybridomas by the limiting dilution method (LDM) are tedious, inefficient, and time- and cost-consuming, especially for hapten molecules. Here, we describe a single transgenic hybridoma selection method (STHSM) that employs a transgenic Sp2/0 with an artificial and stable on-cell-surface anchor. The anchor was designed by combining the truncated variant transmembrane domain of EGFR with a biotin acceptor peptide AVI-tag, which was stably integrated into the genome of Sp2/0 via a piggyBac transposon. To ensure the subsequent precise selection of the hybridoma, the number of on-cell-surface anchors of the transfected Sp2/0 for fusion with immunized splenocytes was further normalized by flow cytometry at the single cell level. Then the single antigen-specific transgenic hybridomas were precisely identified and automatically selected using a CellenONE platform based on the fluorescence assay of the on-cell-surface anchor with the corresponding secreted antigen-specific mAb. The STHSM produced 579 single chloramphenicol (CAP)-specific transgenic hybridomas with a positive rate of 62.7% in 10 plates within 2 h by one-step selection, while only 12 single CAP-specific hybridomas with a positive rate of 6.3% in 40 plates required at least 32 days using the LDM with multiple subcloning steps. The best affinity of mAbs from the STHSM was more than 2-fold higher than that of those from the LDM, and this was mainly due to the preaffinity selection based on the on-cell-surface anchors and more interactions between the mAb and CAP. Then the mAbs from the STHSM and LDM were used to develop an immunoassay for CAP in spiked and natural biological samples. The method displayed satisfactory sensitivity, accuracy, and precision, demonstrating that the STHSM we developed is a versatile, practical, and efficient method for mAb discovery.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.2c02299.Additional experimental details, materials, methods, and results, including design of the on-cell-surface anchor, synthesis and characterization of CAP–protein conjugates, characterization of AVI-tag expression, animal immunization and antisera screening, hybridoma preparation by the LDM, preparation of the antibody variable region sequences, and homology modeling and molecular docking of Fvs-CAP (PDF)This article has not yet been cited by other publications.

In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology

A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line

Optimization of in Vitro Immunization Protocol to Produce Antigen Specific Human Monoclonal Antibody by Demonstrating the Role of IL-10

Optimized Protocols for In-Vitro T-Cell-Dependent and T-Cell-Independent Activation for B-Cell Differentiation Studies Using Limited Cells

Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors

Developing a workflow for the isolation of hybridoma cells producing fully human antigen-specific antibodies using a surface IgG detection method

Manipulation of human B cells to confer immortality

Diverse competitor B cell responses to a germline-targeting priming immunogen in human Ig loci transgenic mice

From IgG monoclonals to IgM-like molecules

IL-10 Augments Antibody Production in in Vitro Immunized Lymphocytes by Inducing a Th2-type Response and B Cell Maturation.

High throughput monoclonal antibody generation by immunizing multiple antigens

Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses

In Vitro Induction and Detection of Human B Cells Producing HLA Antibodies

Patterns of isotype commitment in human B cells: limiting dilution analysis of Epstein Barr virus-infected cells

Production and use of antigen tetramers to study antigen-specific B cells

Sensitive detection of antigen-specific T-cells using bead-bound antigen for in vitro re-stimulation

Responses of canine lymphocytes to allogeneic and autologous Islets of Langerhans in mixed cell cultures

CHARACTERIZATION OF AN ANTIGEN‐SPECIFIC FACTOR FROM A HYBRID T‐CELL LINE *

Monoclonal Antibody Discovery Based on Precise Selection of Single Transgenic Hybridomas with an On-Cell-Surface and Antigen-Specific Anchor

Anti-Peptide Antibody Production Elicited by in Vitro Immunization of Human Peripheral Blood Mononuclear Cells

Expression Cloning of Antibodies from Single Human B Cells